Symptoms of depression and anxiety predict mortality in patients undergoing oral anticoagulation: Results from the thrombEVAL study program.

[1]  P. Wild,et al.  Evaluation of oral anticoagulation therapy: Rationale and design of the thrombEVAL study programme , 2015, European journal of preventive cardiology.

[2]  M. Beutel,et al.  Relevance of depression for anticoagulation management in a routine medical care setting: results from the ThrombEVAL study program , 2014, Journal of thrombosis and haemostasis : JTH.

[3]  M. de Antonio,et al.  Fragility is a key determinant of survival in heart failure patients. , 2014, International journal of cardiology.

[4]  P. Cuijpers,et al.  Is excess mortality higher in depressed men than in depressed women? A meta-analytic comparison. , 2014, Journal of affective disorders.

[5]  Jussi Kauhanen,et al.  Trait anxiety and somatic concerns associate with increased mortality risk: a 23-year follow-up in aging men. , 2014, Annals of epidemiology.

[6]  S. Beach,et al.  Collaborative care for depression and anxiety disorders in patients with recent cardiac events: the Management of Sadness and Anxiety in Cardiology (MOSAIC) randomized clinical trial. , 2014, JAMA internal medicine.

[7]  M. Borggrefe,et al.  Position paper on the importance of psychosocial factors in cardiology: Update 2013 , 2014, German medical science : GMS e-journal.

[8]  Pim Cuijpers,et al.  Comprehensive meta-analysis of excess mortality in depression in the general community versus patients with specific illnesses. , 2014, The American journal of psychiatry.

[9]  K. Eagle,et al.  The addition of the Charlson Comorbidity Index to the GRACE Risk Prediction Index improves prediction of outcomes in acute coronary syndrome. , 2014, Population health management.

[10]  K. Pérès,et al.  Hypnotics and mortality in an elderly general population: a 12-year prospective study , 2013, BMC Medicine.

[11]  M. de Antonio,et al.  Depression, antidepressants, and long-term mortality in heart failure. , 2013, International journal of cardiology.

[12]  R. Stewart,et al.  Anxiety and mortality risk in community-dwelling elderly people , 2013, British Journal of Psychiatry.

[13]  S. Bhavnani,et al.  Evaluation of the Charlson Comorbidity Index to Predict Early Mortality in Implantable Cardioverter Defibrillator Patients , 2013, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[14]  C. Celano,et al.  Feasibility and Utility of Screening for Depression and Anxiety Disorders in Patients With Cardiovascular Disease , 2013, Circulation. Cardiovascular quality and outcomes.

[15]  B. Levis,et al.  Does Evidence Support the American Heart Association's Recommendation to Screen Patients for Depression in Cardiovascular Care? An Updated Systematic Review , 2013, PloS one.

[16]  B. Penninx,et al.  Differential mortality rates in major and subthreshold depression: meta-analysis of studies that measured both , 2013, British Journal of Psychiatry.

[17]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[18]  Shah Ebrahim,et al.  European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.

[19]  W. Katon.  Collaborative depression care models: from development to dissemination. , 2012, American journal of preventive medicine.

[20]  C. Reynolds,et al.  A positive 2-item Patient Health Questionnaire depression screen among hospitalized heart failure patients is associated with elevated 12-month mortality. , 2012, Journal of cardiac failure.

[21]  T. Vos,et al.  Cost-Effectiveness of Opportunistic Screening and Minimal Contact Psychotherapy to Prevent Depression in Primary Care Patients , 2011, PloS one.

[22]  Ottavio Alfieri,et al.  Corrigendum to: ‘Guidelines for the management of atrial fibrillation’ [European Heart Journal (2010) 31, 2369–2429 and EP-Europace (2010) 12, 1360–1420] , 2011 .

[23]  G. Fricchione,et al.  Impact of a Depression Care Management Program for Hospitalized Cardiac Patients , 2011, Circulation. Cardiovascular quality and outcomes.

[24]  Wayne. J. Katon,et al.  Epidemiology and treatment of depression in patients with chronic medical illness , 2011, Dialogues in clinical neuroscience.

[25]  A. Camm,et al.  Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). , 2010, European heart journal.

[26]  C. Spitzer,et al.  A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. , 2010, Journal of affective disorders.

[27]  B. Löwe,et al.  An ultra-brief screening scale for anxiety and depression: the PHQ-4. , 2009, Psychosomatics.

[28]  J. Denollet,et al.  Brief Depression Screening with the PHQ-2 Associated with Prognosis Following Percutaneous Coronary Intervention with Paclitaxel-Eluting Stenting , 2009, Journal of General Internal Medicine.

[29]  R. Carney,et al.  Treatment-resistant depression and mortality after acute coronary syndrome. , 2009, The American journal of psychiatry.

[30]  D. Mark,et al.  Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdiscip , 2008, Circulation.

[31]  B. Thombs,et al.  Optimizing Detection of Major Depression Among Patients with Coronary Artery Disease Using the Patient Health Questionnaire: Data from the Heart and Soul Study , 2008, Journal of General Internal Medicine.

[32]  D. Atar,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 ‡ , 2008, European journal of heart failure.

[33]  P. Skapinakis.  The 2-item Generalized Anxiety Disorder scale had high sensitivity and specificity for detecting GAD in primary care , 2007, Evidence-based medicine.

[34]  A. Hoes,et al.  Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.

[35]  B. Löwe,et al.  Detecting and monitoring depression with a two-item questionnaire (PHQ-2). , 2005, Journal of psychosomatic research.

[36]  R. Spitzer,et al.  The Patient Health Questionnaire-2: Validity of a Two-Item Depression Screener , 2003, Medical care.

[37]  M. Tansella,et al.  Subthreshold psychiatric disorders in primary care: prevalence and associated characteristics. , 2003, Journal of affective disorders.

[38]  F R Rosendaal,et al.  A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy , 1993, Thrombosis and Haemostasis.

[39]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[40]  R. Carney,et al.  Aha Scientific Statement , 2022 .